ArticleJournal of clinical hypertension (Greenwich, Conn.)2018

Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension.

Konstantinos Stavropoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.